Mittleman Eye Blogs

Providing lifetime of vision care in a setting of excellence

September 4, 2015

Association Between Serum 25-hydroxyvitamin D Levels and Age-Related Cataracts

Purpose

To investigate associations between serum 25-hydroxyvitamin D levels and age-related cataracts.

Setting

Department of Ophthalmology, College of Medicine, Catholic University of Korea, South Korea.

Design

Observational cross-sectional study.

Methods

Participants aged 40 years or older in the fourth (2008 to 2009) and fifth (2010 to 2012) Korea National Health and Nutrition Examination Survey (KNHANES) had evaluation of their serum 25-hydroxyvitamin D levels and ophthalmic slitlamp examinations to identify cataract. An age-related cataract was defined as the presence of a cortical, nuclear, anterior subcapsular, posterior subcapsular, or mixed cataract or a history of cataract surgery.

Results

The study evaluated eyes of 18 804 patients. The mean levels of serum 25-hydroxyvitamin D were 20.0 ng/mL in men and 17.5 ng/mL in women. In men, but not in women, the odds ratio (OR) for age-related cataracts decreased statistically significantly when the serum 25-hydroxyvitamin D levels were in the highest quintile than when they were in the lowest quintile (OR, 0.76; 95% confidence interval, 0.59-0.99) after adjusting for potentially confounding factors including age, sex, smoking status, diabetes, hypertension, and sunlight exposure. However, trend analysis did not show a significant declining trend in the cataract risk associated with higher serum 25-hydroxyvitamin D quintiles (P = .084). In women, serum 25-hydroxyvitamin D levels were not associated with age-related cataracts.

Conclusions

The age-related cataract risk decreased in men with higher serum 25-hydroxyvitamin D levels than in those with lower serum 25-hydroxyvitamin D levels after adjusting for potential confounding factors. In light of previous research indicating an antioxidative effect of vitamin D, the connection between vitamin D and age-related cataract warrants further study.

Financial Disclosure

Neither author has a financial or proprietary interest in any material or method mentioned.

Other Blogs

Eye office myths are common, and a wide variety exists—from the feeling of receiving too many tests to thinking that all catar…
We’re here to continue our “Through the Eyes of Dr. Mittleman” recap! A workplace culture of care has been shown to increase e…
Do you or someone you know have tattoos? Did you know that there’s an increasingly significant connection between tattoos and …

Mittleman Eye SMS Policy

Providing lifetime of vision care in a setting of excellence

SMS Policy

By opting into SMS from a web form or other medium, you are agreeing to receive SMS messages from Mittleman Eye. This includes SMS messages for conversations (external). Message frequency varies.

SMS Disclosures

Questions?

If you have questions about this Notice, you may call the Privacy Officer at 561-500-2020